|
US regulators on Wednesday approved the first gene therapy against cancer - a treatment that uses a patient's own immune cells to fight leukemia - opening a new era in the fight against one of the world's top killers. 美国监管机构于8月30日批准了首个对抗癌症的基因治疗手段——使用患者的免疫细胞对抗白血病。白血病是世界上致死率最高的疾病之一，该治疗手段开启了对抗白血病的新纪元。 The treatment is made by Novartis and is called Kymriah. 该疗法由诺华公司研发，并被命名为Kymriah。 This type of anti-cancer immunotherapy, known as a CAR-T cell therapy, was known by CTL019 until now. 这种对抗癌症的免疫疗法也被称作CAR-T细胞疗法，并因CTL019疗法（一种CAR-T细胞疗法）被人们熟知。 | 
